These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9286141)

  • 21. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antithrombotic therapy in atrial fibrillation].
    da Costa JT
    Acta Med Port; 1999; 12(7-11):245-54. PubMed ID: 10707462
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antithrombotic and thrombolytic treatments: current concepts from the North American guidelines and French practice].
    J Mal Vasc; 2005 Sep; 30 Spec No 2():2S8-2S79. PubMed ID: 16392541
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antithrombotic treatment of atrial fibrillation in hospital].
    Thomassen G; Hansen MS; Nordøy A; Hansen JB
    Tidsskr Nor Laegeforen; 2001 Oct; 121(24):2800-4. PubMed ID: 11706483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence, prevalence, and antithrombotic management of atrial fibrillation in elderly Germans.
    Ohlmeier C; Mikolajczyk R; Haverkamp W; Garbe E
    Europace; 2013 Oct; 15(10):1436-44. PubMed ID: 23487542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombotic therapy in atrial fibrillation.
    Laupacis A; Albers G; Dalen J; Dunn MI; Jacobson AK; Singer DE
    Chest; 1998 Nov; 114(5 Suppl):579S-589S. PubMed ID: 9822064
    [No Abstract]   [Full Text] [Related]  

  • 27. [The assessment of the thromboembolic risk and the role of antithrombotic prophylaxis in nonrheumatic atrial fibrillation].
    Fera MS; Giovannini E
    G Ital Cardiol; 1999 Feb; 29(2):193-213. PubMed ID: 10088078
    [No Abstract]   [Full Text] [Related]  

  • 28. [Thromboembolic complications in the course of non-valvular atrial fibrillation].
    Mas JL
    Rev Prat; 1995 Apr; 45(8):935-41. PubMed ID: 7761775
    [No Abstract]   [Full Text] [Related]  

  • 29. Antithrombotic therapy in atrial fibrillation: a review of randomized trials with special reference to the Stroke Prevention in Atrial Fibrillation II (SPAF II) Trial.
    Shivkumar K; Jafri SM; Gheorghiade M
    Prog Cardiovasc Dis; 1996; 38(4):337-42. PubMed ID: 8552791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombotic therapy for atrial fibrillation with stable coronary artery disease: a meta-analysis of randomized controlled trials.
    Kheiri B; Simpson TF; Stecker EC; Osman M; Rahmouni H; Zahr F; Nazer B; Cigarroa JE
    J Thromb Thrombolysis; 2020 Aug; 50(2):395-398. PubMed ID: 31981041
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antithrombotic treatment of atrial fibrillation].
    Connelly SJ; Turpie AG
    Can J Cardiol; 1996 Feb; 12 Suppl A():14A-18A. PubMed ID: 8673946
    [No Abstract]   [Full Text] [Related]  

  • 32. Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation.
    Flaker GC; McGowan DJ; Boechler M; Fortune G; Gage B
    Am Heart J; 1999 Feb; 137(2):307-12. PubMed ID: 9924165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial.
    Man-Son-Hing M; Laupacis A; O'Connor AM; Biggs J; Drake E; Yetisir E; Hart RG
    JAMA; 1999 Aug; 282(8):737-43. PubMed ID: 10463708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antithrombotic therapy of atrial fibrillation].
    Mélon P
    Rev Med Liege; 2000 Apr; 55(4):297-301. PubMed ID: 10909317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombotic therapy. ESC guidelines vs JCS guidelines.
    Inoue H
    Circ J; 2010 Nov; 74(12):2542-5. PubMed ID: 21060203
    [No Abstract]   [Full Text] [Related]  

  • 36. The sin of omission: a systematic review of antithrombotic therapy to prevent stroke in atrial fibrillation.
    Jacobs LG
    J Am Geriatr Soc; 2001 Jan; 49(1):91-4. PubMed ID: 11207849
    [No Abstract]   [Full Text] [Related]  

  • 37. Antithrombotic therapy in atrial fibrillation.
    Venes D
    Chest; 1993 Dec; 104(6):1939-40. PubMed ID: 8253002
    [No Abstract]   [Full Text] [Related]  

  • 38. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
    Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH
    Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Underuse of antithrombotic therapy in stroke patients with chronic atrial fibrillation.
    Villa A; Bacchetta A; Omboni E
    Stroke; 2000 Sep; 31(9):2266-7. PubMed ID: 10978142
    [No Abstract]   [Full Text] [Related]  

  • 40. [The current indications for antithrombotic treatment in valve disease].
    del Río del Busto A; Pardo Vigo A
    Rev Esp Cardiol; 1991 Mar; 44(3):190-202. PubMed ID: 2047549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.